Non-Small Cell Lung Cancer | Oncology Today with Dr Neil Love: Management of Metastatic Non-Small Cell Lung Cancer without an Actionable Mutation (Companion Faculty Lecture)

Featuring a slide presentation and related discussion from Dr Edward Garon, including the following topics:

• Immune checkpoint inhibitor therapy for treatment-naïve advanced non-small cell lung cancer (NSCLC) without an actionable mutation (0:00)

• Duration of immunotherapy in the frontline setting for NSCLC with no targetable mutation (13:43)

• New treatment strategies for relapsed or refractory NSCLC with no targetable mutation (16:25)

• Management of antibody-drug conjugate-associated toxicity (19:08)

• Activity of antibody-drug conjugates alone or in combination with anti-PD-1 antibodies (26:18)

CME information and select publications